Scarica l'app Stockscreener
0.7959
0.03%
-0.0002
Dopo l'orario di chiusura:
.79
-0.0059
-0.74%
Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie
Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline - MarketBeat
Rani Therapeutics | SCHEDULE 13G/A: Others - Moomoo
RA Capital details 11,530,414 Rani Therapeutics (RANI) shares under 9.99% cap - Stock Titan
Rani Therapeutics | 10-Q: Q2 2026 Earnings Report - Moomoo
Rani Therapeutics Holdings earnings beat by $0.01, revenue topped estimates - Investing.com Canada
8-K: Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Updatemoomoo - Moomoo
Rani Therapeutics (NASDAQ:RANI) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Rani Therapeutics Q2 Results: EPS beats estimate, sales up 85% - scanx.trade
Rani Therapeutics (RANI) boosts liquidity with $20M raise and Chugai revenue - Stock Titan
Rani Therapeutics reports Q2 2026: $1.7M contract revenue, $8.4M quarterly net loss, $53.4M cash - TradingView
Rani Therapeutics' Oral RT-114 Tops 150% Bioavailability - Stock Titan
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update - GlobeNewswire
Rani Therapeutics at Canaccord Genuity conference: oral biologics push By Investing.com - Investing.com Canada
RANI: Oral biologics platform shows strong clinical and business momentum, with funding secured into 2027 - TradingView
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Rani Therapeutics CEO, CFO to Present, Hold 1x1 Meetings Aug. 12 - Stock Titan
IMDX Stock Price and Chart — NASDAQ:IMDX - TradingView
Rani Therapeutics Holdings Inc (RANI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
RANI Q2'26 Earnings: EPS estimate is (0.05) USD - TradingView
Rani Therapeutics appoints Michelle Gilson to board By Investing.com - Investing.com UK
Rani Therapeutics Holdings, Inc. (RANI) awards 247,200 stock options to director - Stock Titan
Rani Therapeutics Holdings, Inc. (RANI) details director option holding - Stock Titan
Rani Therapeutics files Form 3 for director Michelle Gilson - Bitget
Rani Therapeutics appoints Michelle Gilson to board - Investing.com
Rani Therapeutics Appoints Michelle Gilson to Board of Directors and Names Her Audit Committee Chair - Quiver Quantitative
Rani Therapeutics appoints Michelle Gilson to board and as Audit Committee chair - TradingView
Rani Therapeutics Appoints Michelle Gilson to Board of Directors - Yahoo Finance
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Enterprise value to EBITDA forward of Rani Therapeutics Holdings, Inc. – NASDAQ:RANI - tradingview.com
Vanguard Capital Management discloses 5,052,862 Rani Therapeutics (RANI) shares in ownership report - Stock Titan
CCORF Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Rani Therapeutics (NASDAQ:RANI) CEO Buys 35,000 Shares - MarketBeat
Rani Therapeutics Holdings Inc (RANI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rani Therapeutics Holdings Inc - TradingKey
Rani Therapeutics Holdings Inc (RANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rani Therapeutics Holdings Inc (RANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RANI|Rani Therapeutics Holdings Inc|Price:0.810|Chg%:-0.000 - TradingKey
Rani Therapeutics Holdings Inc (RANI) Institutional Confidence - TradingKey
RANI|Rani Therapeutics Holdings Inc|Price:0.805|Chg%:+0.007 - TradingKey
Rani Therapeutics Hldgs Market Sentiment - Benzinga España
RANI|Rani Therapeutics Holdings Inc|Price:0.801|Chg%:-0.009 - TradingKey
TradingKey - TradingKey
Rani Therapeutics Holdings Inc (RANI) Cash Flow - TradingKey
Rani Therapeutics Holdings Inc (RANI) Balance Sheet - TradingKey
Rani Therapeutics director Mir A Imran buys $24,839 in stock - Investing.com UK
Form 4 Rani Therapeutics Holdings Inc For: 24 July By Investing.com - Investing.com South Africa
Rani Therapeutics director Mir A Imran buys $24,839 in stock By Investing.com - Investing.com Nigeria
Rani Therapeutics Holdings Inc. (RANI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director IMRAN MIR A - Moomoo
Rani Therapeutics (RANI) insider Imran Mir A buys 36,000 shares - Stock Titan
Rani Therapeutics Holdings (NASDAQ:RANI) surges 29%, shrinking Nasdaq compliance deficit to 11% - TechStock²
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Form 4 Rani Therapeutics Holdings Inc For: 22 July By Investing.com - Investing.com South Africa
Rani Therapeutics CEO Talat Imran buys $25,193 in stock By Investing.com - Investing.com UK
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Javadi Alireza - Moomoo
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Form 4 Rani Therapeutics Holdings Inc For: 21 July By Investing.com - Investing.com Nigeria
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):